Martin Dalin

Institute of Clinical Sciences University of Gothenburg

Claim

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 40 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Figure S4 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis

Torben Ek,Raghda R. Ibrahim,Hartmut Vogt,Kleopatra Georgantzi,Catarina Träger,Jennie Gaarder,Anna Djos,Ida Rahmqvist,Elisabeth Mellström,Fani Pujol-Calderón,Christoffer Vannas,Lina Hansson,Henrik Fagman,Diana Treis,Susanne Fransson,Tobias Österlund,Tzu-Po Chuang,Bronte Manouk Verhoeven,Anders Ståhlberg,Ruth H. Palmer,Bengt Hallberg,Tommy Martinsson,Per Kogner,Martin Dalin

crossref（2024）

Cited0Views0Bibtex

Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis

Torben Ek,Raghda R. Ibrahim,Hartmut Vogt,Kleopatra Georgantzi,Catarina Trager,Jennie Gaarder,Anna Djos,Ida Rahmqvist,Elisabeth Mellstroem,Fani Pujol-Calderon,Christoffer Vannas,Lina Hansson,Henrik Fagman,Diana Treis,Susanne Fransson,Tobias Osterlund,Tzu-Po Chuang,Bronte Manouk Verhoeven,Anders Stahlberg,Ruth H. Palmer,Bengt Hallberg,Tommy Martinsson,Per Kogner,Martin Dalin

CANCER RESEARCH COMMUNICATIONSno. 9 (2024): 2553-2564

Cited0Views0WOSBibtex

Personalized Circulating Tumor DNA Analysis for Sensitive Disease Monitoring and Detection of Relapse in Neuroblastoma

Ida Rahmqvist, Enya Engström,Elisabeth Mellström,Raghda R. Ibrahim,Fani Pujol-Calderón,Agnes Dahlstrand Rudin, Anna Ordqvist Redfors, Niki Rostamzadeh, Rita Di Rienzo, Wilma Franssila, Robert Khashan, Moe Xylander,Christin Karlsson,Torben Ek,Daniel Andersson,Tobias Österlund,Jennie Gaarder,Henrik Fagman,Susanne Fransson,Tommy Martinsson,Anders Ståhlberg,Martin Dalin

Biomarker Researchno. 1 (2024): 1-6

Cited0Views0WOSBibtex

Figure 4 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis

crossref（2024）

Cited0Views0Bibtex

Table 2 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis

crossref（2024）

Cited0Views0Bibtex

Figure S3 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis

crossref（2024）

Cited0Views0Bibtex

Figure 6 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis

crossref（2024）

Cited0Views0Bibtex

Figure 3 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis

crossref（2024）

Cited0Views0Bibtex

Supplementary Data 3 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis

crossref（2024）

Cited0Views0Bibtex

Figure 5 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis

crossref（2024）

Cited0Views0Bibtex

Author Statistics

#Papers: 40

#Citation: 2299

H-Index: 15

G-Index: 18

Sociability: 5

Diversity: 2

Activity: 0

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn